These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36172876)

  • 1. Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials.
    Venter F; Sokhela S; Calmy A; Siedner MJ; Khoo S; Clayden P; Mkhondwane L; Bosch B; Chandiwana N; Hill A; Marconi VC; Boffito M; Sekwese K; Ali M; Delaporte E; Pozniak A; Mashabane N; Lalla-Edwards S; Carman M; Collins S
    AIDS; 2022 Nov; 36(13):1900-1901. PubMed ID: 36172876
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: weight gain stopping/switch rules for antiretroviral clinical trials.
    Taramasso L; Di Biagio A; Guaraldi G
    AIDS; 2022 Nov; 36(13):1899-1900. PubMed ID: 36172875
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight gain stopping/switch rules for antiretroviral clinical trials.
    Venter WDF; Sokhela S; Calmy A; Mkhondwane L; Bosch B; Chandiwana N; Hill A; Sekwese K; Mashabane N; Pozniak A; Khoo S; Ali M; Delaporte E; Lalla-Edwards S; Clayden P; Marconi VC; Siedner MJ; Boffito M; Serenata C; Carman M; Collins S
    AIDS; 2021 Dec; 35(Suppl 2):S183-S188. PubMed ID: 34848585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain stopping/switch rules for antiretroviral clinical trials.
    Kouamou V; Inzaule S; Manasa J
    AIDS; 2022 Jun; 36(7):1053-1054. PubMed ID: 35652678
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials.
    Erlandson KM; Carter CC; Melbourne K; Brown TT; Cohen C; Das M; Esser S; Huang H; Koethe JR; Martin H; McComsey GA; Orkin C; Post FA; Rockstroh JK; Sax PE; Stellbrink HJ; Waters L; Wei X; Lake JE
    Clin Infect Dis; 2021 Oct; 73(8):1440-1451. PubMed ID: 33987636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies.
    Zohar S; Chevret S
    Stat Med; 2001 Oct; 20(19):2827-43. PubMed ID: 11568943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.
    Lake JE; Wu K; Bares SH; Debroy P; Godfrey C; Koethe JR; McComsey GA; Palella FJ; Tassiopoulos K; Erlandson KM
    Clin Infect Dis; 2020 Dec; 71(9):e471-e477. PubMed ID: 32099991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of weight gain after antiretroviral switch to integrase strand transfer inhibitor or tenofovir alafenamide-based therapy.
    Sjaarda A; Bernstein A; Sparks A; Saber S; Siegel M
    Infection; 2022 Apr; 50(2):407-412. PubMed ID: 34449049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials.
    Goffin JR; Pond GR
    BMC Med Res Methodol; 2011 Dec; 11():164. PubMed ID: 22151297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight gain before and after switch from TDF to TAF in a U.S. cohort study.
    Mallon PW; Brunet L; Hsu RK; Fusco JS; Mounzer KC; Prajapati G; Beyer AP; Wohlfeiler MB; Fusco GP
    J Int AIDS Soc; 2021 Apr; 24(4):e25702. PubMed ID: 33838004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments on Dupont's article on sequential stopping rules.
    Whitehead J
    Control Clin Trials; 1983 Sep; 4(3):259-60. PubMed ID: 6641237
    [No Abstract]   [Full Text] [Related]  

  • 13. Stopping rules for phase I clinical trials with dose expansion cohorts.
    Devlin SM; Iasonos A; O'Quigley J
    Stat Methods Med Res; 2022 Feb; 31(2):334-347. PubMed ID: 34951338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of stopping rules on heterogeneity of results in overviews of clinical trials.
    Hughes MD; Freedman LS; Pocock SJ
    Biometrics; 1992 Mar; 48(1):41-53. PubMed ID: 1581492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials.
    Goffin JR; Pond GR; Tu D
    BMC Med Res Methodol; 2011 Jun; 11():95. PubMed ID: 21693051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy.
    Erlandson KM; Wu K; Lake JE; Samuels DC; Bares SH; Tassiopoulos K; Koethe JR; Brown TT; Leonard M; Benson CA; Haas DW; Hulgan T;
    AIDS; 2021 Mar; 35(3):439-445. PubMed ID: 33252493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a new multinomial phase II stopping rule using response and early progression.
    Dent S; Zee B; Dancey J; Hanauske A; Wanders J; Eisenhauer E
    J Clin Oncol; 2001 Feb; 19(3):785-91. PubMed ID: 11157032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
    Walter SD; Guyatt GH; Bassler D; Briel M; Ramsay T; Han HD
    Stat Med; 2019 Jun; 38(14):2524-2543. PubMed ID: 30887553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible implementations of group sequential stopping rules using constrained boundaries.
    Burington BE; Emerson SS
    Biometrics; 2003 Dec; 59(4):770-7. PubMed ID: 14969454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of stopping rules for audiological ascending test procedures using computer simulations.
    Marshall L; Hanna TE
    J Speech Hear Res; 1989 Jun; 32(2):265-73. PubMed ID: 2739377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.